doi: 10.1097/HJH.0000000000002450.
Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
Affiliations
- PMID: 32195824
- DOI: 10.1097/HJH.0000000000002450
Item in Clipboard
Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
J Hypertens.
2020 May.
No abstract available
Comment in
-
Chronic Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Is High Among Intensive Care Unit Patients With Non-COVID-19 Sepsis but Carries a Moderately Increased Risk of Death.Hypertension. 2020 Jun;75(6):e15-e16. doi: 10.1161/HYPERTENSIONAHA.120.15178. Epub 2020 Apr 10. Hypertension. 2020. PMID: 32275190 Free PMC article. No abstract available.
-
Switching to another antihypertensive effective drug when using ACEIs/ARBs to treat arterial hypertension during COVID-19.Eur Heart J. 2020 May 14;41(19):1856. doi: 10.1093/eurheartj/ehaa331. Eur Heart J. 2020. PMID: 32324222 Free PMC article. No abstract available.
-
Comment on 'Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?'.J Hypertens. 2020 Jun;38(6):1189-1198. doi: 10.1097/HJH.0000000000002481. J Hypertens. 2020. PMID: 32371810 Free PMC article. No abstract available.
-
Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus.J Hypertens. 2020 Jun;38(6):1190-1191. doi: 10.1097/HJH.0000000000002469. J Hypertens. 2020. PMID: 32371811 Free PMC article. No abstract available.
-
COVID-19, hypertension and angiotensin receptor-blocking drugs.J Hypertens. 2020 Jun;38(6):1191. doi: 10.1097/HJH.0000000000002468. J Hypertens. 2020. PMID: 32371812 Free PMC article. No abstract available.
-
Could renin-angiotensin-aldosterone system inhibitors be used for hypertensive patients with coronavirus disease 2019?J Hypertens. 2020 Jun;38(6):1191-1192. doi: 10.1097/HJH.0000000000002474. J Hypertens. 2020. PMID: 32371813 Free PMC article. No abstract available.
-
Reply: Possible impact of membrane ACE2 expression on COVID-19 infection.J Hypertens. 2020 Jun;38(6):1192-1194. doi: 10.1097/HJH.0000000000002484. J Hypertens. 2020. PMID: 32371814 Free PMC article. No abstract available.
-
Hypertension and predisposition to infection: an important issue during this global pandemic.J Hypertens. 2020 Jun;38(6):1195-1196. doi: 10.1097/HJH.0000000000002471. J Hypertens. 2020. PMID: 32371816 Free PMC article. No abstract available.
-
Angiotensin-converting enzyme-2 in SARS-CoV-2 infection: good or bad?J Hypertens. 2020 Jun;38(6):1196-1197. doi: 10.1097/HJH.0000000000002472. J Hypertens. 2020. PMID: 32371817 Free PMC article. No abstract available.
Similar articles
-
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?JAMA. 2020 May 12;323(18):1769-1770. doi: 10.1001/jama.2020.4812. JAMA. 2020. PMID: 32208485 No abstract available.
-
Facts and reflections on COVID-19 and anti-hypertensives drugs.Drug Discov Ther. 2020 May 6;14(2):105-106. doi: 10.5582/ddt.2020.01017. Epub 2020 Mar 26. Drug Discov Ther. 2020. PMID: 32213760
-
Drugs and the renin-angiotensin system in covid-19.BMJ. 2020 Apr 2;369:m1313. doi: 10.1136/bmj.m1313. BMJ. 2020. PMID: 32241880 No abstract available.
-
COVID-19 and Cardiovascular Disease.Circulation. 2020 May 19;141(20):1648-1655. doi: 10.1161/CIRCULATIONAHA.120.046941. Epub 2020 Mar 21. Circulation. 2020. PMID: 32200663 Review.
-
[The RAAS and SARS-CoV-2: A riddle to solve].Hipertens Riesgo Vasc. 2020 Oct-Dec;37(4):169-175. doi: 10.1016/j.hipert.2020.05.005. Epub 2020 May 27. Hipertens Riesgo Vasc. 2020. PMID: 32527699 Free PMC article. Review. Spanish.
Cited by
-
To Curb the Progression of Fatal COVID-19 Course-Dream or Reality.Curr Hypertens Rep. 2021 Feb 27;23(2):12. doi: 10.1007/s11906-021-01130-z. Curr Hypertens Rep. 2021. PMID: 33638064 Free PMC article. Review.
-
COVID-19 and arterial hypertension: Hypothesis or evidence?J Clin Hypertens (Greenwich). 2020 Jul;22(7):1120-1126. doi: 10.1111/jch.13925. Epub 2020 Jul 6. J Clin Hypertens (Greenwich). 2020. PMID: 32627330 Free PMC article. Review.
-
Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection?Front Immunol. 2020 May 28;11:1239. doi: 10.3389/fimmu.2020.01239. eCollection 2020. Front Immunol. 2020. PMID: 32574273 Free PMC article. Review.
-
Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities.Pharmacol Ther. 2020 Nov;215:107628. doi: 10.1016/j.pharmthera.2020.107628. Epub 2020 Jul 9. Pharmacol Ther. 2020. PMID: 32653530 Free PMC article. Review.
-
Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling.Front Pharmacol. 2020 Jun 3;11:836. doi: 10.3389/fphar.2020.00836. eCollection 2020. Front Pharmacol. 2020. PMID: 32581799 Free PMC article. Review.
References
-
- Zhou P, Yang X, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; https://doi.org/10.1038/s41586-020-2012-7 - DOI
-
- Zisman LS, Keller RS, Weaver B, Lin Q, Speth R, Bristow M, et al. Increased angiotensin-(1-7) forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme homologue ACE2. Circulation 2003; 108:1707–1712.
-
- Gallagher PE, Ferrario CM, Tallant EA. MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides. Am J Physiol Cell Physiol 2008; 295:C1169–C1174.
-
- Jessup JA, Gallagher PE, Averill DB, Brosnihan B, Tallant A, Chappell MC, et al. Effect of angiotension blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats. Am J Physiol Heart Circ 2006; 291:H2166–H2172.
-
- Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 2005; 111:2605–2610.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
